Wyden Explains Case To Keep Commercial Market Drug Price Controls

Senate Finance Committee Chair Ron Wyden on Tuesday (Dec. 7) explained the case his staff is making to the Senate parliamentarian in defense of extending drug price controls to private insurance markets. However, the Oregon Democrat declined to say whether the Senate parliamentarian has identified drug pricing measures in the Build Back Better Act that violate budget reconciliation rules, and a Senate Democratic aide said those details will likely become public after bipartisan meetings, which have yet to be scheduled...